Computational Intelligence in Drug Repurposing for COVID-19

Manish Tripathi; Sujata Sharma; T.P. Singh; A.S. Ethayathulla; Punit Kaur

doi:10.1007/978-981-15-8534-0_14

ScienceGate Book Chapters

BOOK-CHAPTER

Computational Intelligence in Drug Repurposing for COVID-19

Manish Tripathi Sujata Sharma T.P. Singh A.S. Ethayathulla Punit Kaur

Year: 2020 Studies in computational intelligence Pages: 273-294 Publisher: Springer Nature

DOI: 10.1007/978-981-15-8534-0_14

Get Full-Text PDF Get Analytical Report

Keywords:

Drug repositioning Repurposing Pandemic Hydroxychloroquine Coronavirus disease 2019 (COVID-19) Drug Intensive care medicine Medicine Favipiravir Coronavirus Drug discovery Lopinavir Disease Infectious disease (medical specialty) Artificial intelligence Computer science Pharmacology Bioinformatics Biology Pathology

Metrics

Cited By

3.99

FWCI (Field Weighted Citation Impact)

Refs

0.95

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Computational Drug Discovery Methods

Physical Sciences → Computer Science → Computational Theory and Mathematics

SARS-CoV-2 and COVID-19 Research

Health Sciences → Medicine → Infectious Diseases

COVID-19 Clinical Research Studies

Health Sciences → Medicine → Infectious Diseases

Computational Intelligence in Drug Repurposing for COVID-19

Metrics

Citation History

Topics

Related Documents

Drug Repurposing for COVID-19 using Computational Methods

Computational-based drug repurposing methods in COVID-19

Drug Repurposing and Computational Drug Discovery for Viral Infections and COVID-19

Drug Repurposing for COVID 19

Computational Drug Screening in COVID-19 Drug Repurposing Research: Encouraging Findings and Limitations